InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the full record of transactions filed by North Annette, Directeur Juridique. Officer active across 1 companies, notably Turning Point Therapeutics, Inc.. Aggregated, 8 disclosures have been logged. Total volume traded: €43k. The latest transaction was filed on 9 February 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
€21,263669 shares@ €31.78284.6% of flow
Common Stock
SEC:0001209191-22-008981·
€21,263669 shares@ €31.78282.3% of flow
Common Stock
SEC:0001209191-22-008981:0·
€144,10610,000 shares@ €14.410631.4% of flow
Common Stock
SEC:0001209191-21-054117·
€144,10610,000 shares@ €14.410615.7% of flow
Common Stock
SEC:0001209191-21-054117:0·
€210,27315,000 shares@ €14.018245.9% of flow
Common Stock
SEC:0001209191-21-040984·
€210,27315,000 shares@ €14.018222.9% of flow
Common Stock
SEC:0001209191-21-040984:0·
€82,8555,882 shares@ €14.086218.1% of flow
Common Stock
SEC:0001209191-21-030925·
€82,8555,882 shares@ €14.08629.0% of flow
Common Stock
SEC:0001209191-21-030925:0·
8 of 8 declarations
About North Annette
Annette North is the Executive Vice President, General Counsel, and Secretary at Turning Point Therapeutics, Inc. She is responsible for the company's legal affairs and compliance. Annette plays a key role in protecting the legal and regulatory interests of the organization.
